Biotechnology Company
Appears in 1 story
Developing virus-like particle norovirus vaccines
Human norovirus eluded laboratory cultivation for nearly six decades, which prevented vaccine development for a pathogen that sickens 700 million people annually. Baylor College of Medicine researchers broke this barrier using the drug TAK-779 to achieve 10 to 15 consecutive rounds of viral replication in lab-grown human intestinal tissue, yielding stable virus stocks for the first time.
Updated May 27
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
